I founded BioIntelScan. I saw a biologics firm die from one FDA warning letter in 90 days. Now I help clinic owners catch compliance risks before they bite.BioIntelScan.com GlobalJoined May 2026
361 exempt - or does it need an IND? The test: 21 CFR 1271.10(a) - minimal manipulation + homologous use. Our Four-Prong Scanner screens products against the rule. Not legal advice. -> biointelscan.com
The Ninth Circuit reversed for the FDA in the California Stem Cell Treatment Center case (2023). The four-prong precedent just got teeth. Track rulings live. → biointelscan.com
Seven agencies. One timeline.
FDA warning letters. FTC complaints. CBER notices. OPDP letters. SEC actions. State-AG orders. DOJ injunctions — all filtered to regen med and the four-prong case law that shapes it.
The Bloomberg Terminal for regen med → biointelscan.com
Counsel gives advice. BioIntelScan creates the record. Track every FDA, FTC & DOJ action against regenerative-medicine operators, scored against 21 CFR 1271 in real time. Run the Four-Prong Scanner before you commit. biointelscan.com Not legal advice. #regmed#FDA
R3 Stem Cell settled with the FTC ($5M) over unsupported stem-cell claims. Marketing is not evidence. Our Claim Clearance flags unsubstantiated language before it becomes a liability. Not legal advice. -> biointelscan.com
Friday gut-check for regen-med marketers:
Every claim you shipped this week — would it survive a four-prong scan?
Batch-review them in Claim Clearance™ and get a counsel-ready memo before Monday → biointelscan.com/claim-clearance
Stop guessing which claims go "too far." Claim Clearance scores each one against the four-prong test and flags the warning-letter language before you publish. → biointelscan.com/claim-clearance
Guidance changes your risk score the moment it drops.
CBER's draft on sepsis risk + donor screening for HCT/Ps is open for comment now. New rules re-run every 361 registration against tighter criteria.
Track drafts → finals in one place → biointelscan.com
Agencies: you write the copy, you can own the FTC liability. R3 Stem Cell ended in a $5M FTC judgment. Clear every client claim before it ships. → biointelscan.com/claim-clearance
60 seconds. One claim. Four prongs.
Minimal manipulation. Homologous use. No combination. No systemic effect.
Paste your product or indication into the free Four-Prong Scanner and see exactly which prong puts you at risk → biointelscan.com
"Am I one warning letter away from shutting down?"
The question every regen-med clinic owner asks at 2am. BioIntelScan answers it: score every product you offer on the four-prong test, get alerts when peers in your segment catch action.
biointelscan.com
Free Four-Prong Scanner: drop in your product and get an instant read on minimal manipulation, homologous use, combination, and systemic effect. → biointelscan.com
The Bloomberg Terminal for regenerative medicine. BioIntelScan tracks every FDA, FTC & DOJ enforcement action, scored against 21 CFR 1271, in real time. Know who's regulated before your capital does. biointelscan.com Not legal advice. #regmed#FDA
The FDA has issued warning letters to exosome marketers (New Life, Chara, Lux). No exosome product is FDA-approved to treat disease. Know the regulatory status before you buy in - we track every warning letter. Not legal advice. -> biointelscan.com
The four-prong test isn't theoretical. It's been litigated.
US Stem Cell Clinic: federal injunction barring SVF for unapproved uses. California Stem Cell: Ninth Circuit reversed for the FDA in 2023.
The case law that shapes your risk → biointelscan.com
The 2024-25 exosome sweep: New Life Medical, Chara Biologics and Lux Therapeutics all hit with FDA warning letters. Is exosome therapy on your menu? → biointelscan.com
Agencies: you're liable for the claims you put in market.
Claim Clearance™ lets you paste 50 headlines, CTAs, and disclaimers and get 50 verdicts — each scored against CFR + case law, with a counsel-ready memo per campaign.
Clear it before it ships → biointelscan.com
1 Followers 23 FollowingCompliance-focused biologic education and professional access facilitation aligned with 21 CFR Part 1271. Licensed providers only.
1 Followers 23 FollowingCompliance-focused biologic education and professional access facilitation aligned with 21 CFR Part 1271. Licensed providers only.
867 Followers 81 FollowingGrowing3's Influencer Matcher is your all-in-one solution to discover and connect with the most impactful Web3 influencers, empowering your marketing strategy.
418 Followers 419 FollowingMedical & Scientific New Discovery 🧬🔭|
Natural Hair Regrowth & Height Increase | The Surprising Case of Muhammad Qasim Dreams Miracles
4.3M Followers 171 FollowingEngineer. Selecting and curating pictures and videos trying to awaken your sense of wonder since 2014. Science, tech, art, weather, space, the unusual around us
3K Followers 3K FollowingFamily doc. 10yr Major https://t.co/KweMVD2s1G, CFB, Music-wide range, Fine Tequila. Give Maine to Canada, we'll take Alberta. DMs only if Informative!
NO trolls or Bitcoin
787 Followers 64 FollowingCommunity focused on the proactive development of humanity, promoting education, science, and technology.
We spark synapses across the world wide web. ⚡🧠✨
331K Followers 1K FollowingI seek the truth and share it but...
📝Disclaimer: Posts made are not personalized nor financial advice for the viewer and are for entertainment purposes only.
15K Followers 525 FollowingAccelerating world class science to deliver transformative regenerative medicine treatments in an equitable manner to a diverse California and world
19K Followers 576 FollowingThe ISSCR is a global, nonprofit organization that promotes excellence in stem cell science and applications to human health.
12K Followers 1K FollowingThe Regulatory Affairs Professionals Society (RAPS) is an international membership organization of regulatory professionals in the healthcare products sector.
643K Followers 15 FollowingOur posts are FDA Approved! Get notified about the U.S. Food and Drug Administration's recalls. Privacy Policy - https://t.co/AUq6FZbkjz
6K Followers 330 FollowingPink Sheet delivers analysis & commentary focused on regulatory implications, including high value perspectives from insiders & thought leaders across the globe
128K Followers 799 FollowingBiotech reporter @statnews. Dog ❤️er. Polk Award winner. #COYS. Said one analyst: The likes of Adam Feuerstein attack viciously. On Signal: stataf.54
3.2M Followers 237 FollowingThe latest business and financial news from around the 🌍 with insights from @breakingviews.
Our new daily podcast is here: https://t.co/WoRUGLyyeH
1.1M Followers 2K FollowingLeadership on #food, #agriculture, natural resources, #rural development, #nutrition, & related issues based on public policy, science, & effective management.
44K Followers 68 FollowingOfficial FBI Columbia X. Submit tips at https://t.co/MTctswxTGw. Public info may be used for authorized purposes: https://t.co/HQc9w09IwW.
4.0M Followers 2K FollowingOfficial FBI X account. Submit tips at https://t.co/tGqFRcJykB. Public info may be used for authorized purposes: https://t.co/x6bfDUEYeJ.
1.8M Followers 378 FollowingThe Wall Street Journal's Business editors share the latest breaking news and their insights on what matters most in business and finance.
3.7M Followers 56 FollowingWe are the Nation's first line of defense. We accomplish what others cannot accomplish and go where others cannot go.
https://t.co/yhjtYvG98h